JAK2 V617F mutations and thrombosis in BCR-ABL1 negative myeloproliferative neoplasms: clinical profile and hematologic insights
Leukemia Research Reports · 2026 · 25 · 100588
DOI: 10.1016/j.lrr.2026.100588 ↗Kurz gefasst
Fachartikel in der Zeitschrift Leukemia Research Reports, 2026. Verfasst von Anna Mira Lubis und 3 weiteren Autor:innen. Beteiligte Einrichtung: Division of Hematology and Medical Oncology, Department of Internal Medicine, Faculty of Medicine Universitas Indonesia, Cipto Mangunkusumo General H…. Die Arbeit nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Hematology and Medical Oncology, Department of Internal Medicine, Faculty of Medicine Universitas Indonesia, Cipto Mangunkusumo General Hospital, Jakarta, Indonesia.
- Faculty of Medicine, Universitas Indonesia, Jakarta, Indonesia.
- Department of Anatomical Pathology, Faculty of medicine Universitas Indonesia, Cipto Mangunkusumo Hospital, Jakarta, Indonesia.
Zitieren
APA
Lubis, A. M., Baskoro, M. O., Anindyah, G., & Harahap, A. S. (2026). JAK2 V617F mutations and thrombosis in BCR-ABL1 negative myeloproliferative neoplasms: clinical profile and hematologic insights. Leukemia Research Reports, 25, 100588. https://doi.org/10.1016/j.lrr.2026.100588
Vancouver
Lubis AM, Baskoro MO, Anindyah G, Harahap AS. JAK2 V617F mutations and thrombosis in BCR-ABL1 negative myeloproliferative neoplasms: clinical profile and hematologic insights. Leukemia Research Reports. 2026;25:100588. doi:10.1016/j.lrr.2026.100588
BibTeX
@article{Lubis2026,
author = {Lubis, Anna Mira and Baskoro, Muhammad Orri and Anindyah, Gabriella and Harahap, Agnes Stephanie},
title = {JAK2 V617F mutations and thrombosis in BCR-ABL1 negative myeloproliferative neoplasms: clinical profile and hematologic insights},
journal = {Leukemia Research Reports},
year = {2026},
volume = {25},
pages = {100588},
doi = {10.1016/j.lrr.2026.100588}
}
EUVIMED